Conferences 1Cell.Ai is attending in 2026–2027

LinkedIn 1cell.ai

1Cell.Ai is listed at 3 conferences on Tnuki's calendar in 2026–2027: ESMO 2026 (exhibiting), ISLB 2026 (on the program) and ASCO 2027 (exhibiting). 1Cell.Ai makes a single-cell analysis platform and AI tools for cancer research and precision oncology. As of Oct 17, 2026.

Show
ConferenceDetailsInvolvementTnuki guide
ESMO Congress 2026Europe’s medical oncologists & cancer researchersOfficial site
Madrid, Spain ~37k attendees ExhibitorAs published by European Society for Medical Oncology
Booth 1107
Attendee mix: Mostly clinical; oncologists, KOLs, cancer researchers, medical affairs and oncology biopharma teams
Open the guide Search and filter attendees
ISLB 2026 — 8th Annual Congress of Liquid BiopsyLiquid biopsy researchers & diagnostics companiesOfficial site
Madrid, Spain ~700 attendees On the programNo booth or sponsorship in the organizer’s published lists
Program 2 posters
Attending
  • Principal Scientist - Clinical Genomics
  • Senior Research Scientist
Attendee mix: Evenly mixed academia & industry; liquid biopsy researchers, oncologists and diagnostics developers
Open the guide Search and filter attendees
ASCO Annual Meeting 2027World’s largest clinical oncology meetingOfficial site
Chicago, IL ~44k attendees ExhibitorAs published by American Society of Clinical Oncology
Booth 24016
Attendee mix: Mostly clinical; oncologists, KOLs, clinical researchers, medical affairs and oncology biopharma teams
Open the guide Search and filter attendees

We hold published exhibitor, sponsor, program or attendee lists for 54 of the 156 conferences on our calendar, so this page shows 1Cell.Ai’s involvement at those 54 only — it is not a complete record of where they go. Organizers typically publish a list around six months before the event, so coverage grows over time.

Instantly find decision makers at 1Cell.Ai

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

See what Tnuki can do

Explore our deep integration of account and market intelligence, in one easy-to-use chat.

Or talk to a human →